Given the lower IC50 and Emax values, ceftriaxone had high potency and efficacy, respectively, in MYCN‐amplified tumor cells compared with that in MYCN‐nonamplified tumor cells (Fig. 1F,G). This evidence concerns the gene MYCN and neoplasm.